Structure

Physi-Chem Properties

Molecular Weight:  372.12
Volume:  363.327
LogP:  3.361
LogD:  2.797
LogS:  -4.03
# Rotatable Bonds:  1
TPSA:  116.45
# H-Bond Aceptor:  7
# H-Bond Donor:  4
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.608
Synthetic Accessibility Score:  3.842
Fsp3:  0.35
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.002
MDCK Permeability:  1.068867823050823e-05
Pgp-inhibitor:  0.045
Pgp-substrate:  0.986
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.037
30% Bioavailability (F30%):  0.952

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.053
Plasma Protein Binding (PPB):  92.6930923461914%
Volume Distribution (VD):  0.837
Pgp-substrate:  7.27635383605957%

ADMET: Metabolism

CYP1A2-inhibitor:  0.548
CYP1A2-substrate:  0.172
CYP2C19-inhibitor:  0.211
CYP2C19-substrate:  0.062
CYP2C9-inhibitor:  0.743
CYP2C9-substrate:  0.818
CYP2D6-inhibitor:  0.613
CYP2D6-substrate:  0.207
CYP3A4-inhibitor:  0.618
CYP3A4-substrate:  0.177

ADMET: Excretion

Clearance (CL):  14.561
Half-life (T1/2):  0.624

ADMET: Toxicity

hERG Blockers:  0.054
Human Hepatotoxicity (H-HT):  0.467
Drug-inuced Liver Injury (DILI):  0.798
AMES Toxicity:  0.04
Rat Oral Acute Toxicity:  0.939
Maximum Recommended Daily Dose:  0.966
Skin Sensitization:  0.931
Carcinogencity:  0.761
Eye Corrosion:  0.003
Eye Irritation:  0.409
Respiratory Toxicity:  0.942

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC174953

Natural Product ID:  NPC174953
Common Name*:   Sigmoidin D
IUPAC Name:   (2S)-2-[(3S)-3,8-dihydroxy-2,2-dimethyl-3,4-dihydrochromen-6-yl]-5,7-dihydroxy-2,3-dihydrochromen-4-one
Synonyms:   Sigmoidin D
Standard InCHIKey:  ASQDBJSRWIDYKK-RDJZCZTQSA-N
Standard InCHI:  InChI=1S/C20H20O7/c1-20(2)17(25)5-10-3-9(4-14(24)19(10)27-20)15-8-13(23)18-12(22)6-11(21)7-16(18)26-15/h3-4,6-7,15,17,21-22,24-25H,5,8H2,1-2H3/t15-,17-/m0/s1
SMILES:  CC1(C)[C@H](Cc2cc(cc(c2O1)O)[C@@H]1CC(=O)c2c(cc(cc2O1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL516331
PubChem CID:   129362
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0000337] Flavans
          • [CHEMONTID:0003643] 3'-prenylated flavans
            • [CHEMONTID:0003506] 3'-prenylated flavanones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota stem bark n.a. n.a. PMID[17489632]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. stem n.a. PMID[18484536]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota stem bark Mukono, Uganda 2005-JUN PMID[19008110]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19836230]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[20337486]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[21116437]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 > 60000.0 nM PMID[532771]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC174953 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9934 High Similarity NPC472632
0.9934 High Similarity NPC473990
0.9869 High Similarity NPC474033
0.9869 High Similarity NPC474034
0.9804 High Similarity NPC471211
0.9804 High Similarity NPC471212
0.9804 High Similarity NPC134783
0.9804 High Similarity NPC471210
0.9804 High Similarity NPC474038
0.9739 High Similarity NPC472631
0.9739 High Similarity NPC472630
0.9739 High Similarity NPC475784
0.9739 High Similarity NPC119209
0.9739 High Similarity NPC118256
0.9739 High Similarity NPC192686
0.9737 High Similarity NPC472598
0.9737 High Similarity NPC27337
0.9737 High Similarity NPC474055
0.9737 High Similarity NPC471209
0.9735 High Similarity NPC200761
0.9735 High Similarity NPC477503
0.9735 High Similarity NPC45849
0.9735 High Similarity NPC470327
0.9679 High Similarity NPC471213
0.9677 High Similarity NPC472625
0.9675 High Similarity NPC472634
0.9675 High Similarity NPC26326
0.9671 High Similarity NPC35038
0.9671 High Similarity NPC195796
0.9671 High Similarity NPC470328
0.9671 High Similarity NPC209614
0.9671 High Similarity NPC291878
0.9671 High Similarity NPC472626
0.9671 High Similarity NPC278778
0.9669 High Similarity NPC74924
0.9618 High Similarity NPC6588
0.9618 High Similarity NPC117854
0.9618 High Similarity NPC477154
0.9618 High Similarity NPC474024
0.9615 High Similarity NPC293319
0.9615 High Similarity NPC62261
0.9613 High Similarity NPC472635
0.9613 High Similarity NPC476247
0.961 High Similarity NPC282009
0.961 High Similarity NPC287328
0.961 High Similarity NPC472624
0.961 High Similarity NPC470326
0.9608 High Similarity NPC291508
0.9608 High Similarity NPC223787
0.9608 High Similarity NPC284820
0.9608 High Similarity NPC52889
0.9608 High Similarity NPC473272
0.9605 High Similarity NPC321779
0.9603 High Similarity NPC106976
0.9551 High Similarity NPC186686
0.9551 High Similarity NPC124038
0.9548 High Similarity NPC471499
0.9548 High Similarity NPC142252
0.9545 High Similarity NPC117418
0.9545 High Similarity NPC53545
0.9545 High Similarity NPC22192
0.9539 High Similarity NPC298692
0.9539 High Similarity NPC213896
0.9539 High Similarity NPC192083
0.9539 High Similarity NPC18727
0.9536 High Similarity NPC474023
0.9536 High Similarity NPC474021
0.9494 High Similarity NPC477502
0.9487 High Similarity NPC220912
0.9487 High Similarity NPC474150
0.9487 High Similarity NPC474162
0.9484 High Similarity NPC36217
0.9477 High Similarity NPC226025
0.9474 High Similarity NPC471982
0.9474 High Similarity NPC475790
0.9474 High Similarity NPC219582
0.9474 High Similarity NPC302950
0.9474 High Similarity NPC236637
0.947 High Similarity NPC338131
0.943 High Similarity NPC43319
0.9427 High Similarity NPC152659
0.9427 High Similarity NPC248638
0.9427 High Similarity NPC236521
0.9423 High Similarity NPC173137
0.9423 High Similarity NPC228383
0.9423 High Similarity NPC158188
0.9423 High Similarity NPC289771
0.9419 High Similarity NPC204879
0.9419 High Similarity NPC95936
0.9419 High Similarity NPC184755
0.9419 High Similarity NPC250214
0.9419 High Similarity NPC74178
0.9416 High Similarity NPC250922
0.9416 High Similarity NPC470600
0.9416 High Similarity NPC320825
0.9416 High Similarity NPC13858
0.9416 High Similarity NPC326037
0.9416 High Similarity NPC471985
0.9371 High Similarity NPC218226
0.9367 High Similarity NPC36
0.9367 High Similarity NPC300053
0.9367 High Similarity NPC7688
0.9367 High Similarity NPC108433
0.9367 High Similarity NPC475888
0.9367 High Similarity NPC125039
0.9367 High Similarity NPC72787
0.9367 High Similarity NPC58223
0.9367 High Similarity NPC224280
0.9367 High Similarity NPC7154
0.9367 High Similarity NPC36916
0.9363 High Similarity NPC472964
0.9363 High Similarity NPC211107
0.9363 High Similarity NPC201800
0.9363 High Similarity NPC472448
0.9363 High Similarity NPC83922
0.9363 High Similarity NPC25152
0.9359 High Similarity NPC204290
0.9359 High Similarity NPC471976
0.9359 High Similarity NPC328102
0.9359 High Similarity NPC101731
0.9359 High Similarity NPC472902
0.9359 High Similarity NPC470183
0.9359 High Similarity NPC321399
0.9355 High Similarity NPC475267
0.9355 High Similarity NPC471479
0.9355 High Similarity NPC78071
0.9355 High Similarity NPC474681
0.9355 High Similarity NPC48208
0.9355 High Similarity NPC218313
0.9355 High Similarity NPC474208
0.9355 High Similarity NPC52530
0.9355 High Similarity NPC262286
0.9355 High Similarity NPC471515
0.9355 High Similarity NPC36852
0.9355 High Similarity NPC474836
0.9355 High Similarity NPC162869
0.9355 High Similarity NPC67876
0.9355 High Similarity NPC156057
0.9355 High Similarity NPC78225
0.9351 High Similarity NPC234255
0.9351 High Similarity NPC117992
0.9351 High Similarity NPC152951
0.9351 High Similarity NPC477958
0.9351 High Similarity NPC57674
0.9351 High Similarity NPC230149
0.9351 High Similarity NPC256925
0.9351 High Similarity NPC168247
0.9346 High Similarity NPC472912
0.9317 High Similarity NPC256760
0.9313 High Similarity NPC326877
0.9313 High Similarity NPC475212
0.9313 High Similarity NPC288813
0.9308 High Similarity NPC207575
0.9308 High Similarity NPC119589
0.9308 High Similarity NPC236934
0.9308 High Similarity NPC5778
0.9308 High Similarity NPC120593
0.9308 High Similarity NPC170245
0.9308 High Similarity NPC13481
0.9304 High Similarity NPC18100
0.9304 High Similarity NPC7483
0.9304 High Similarity NPC273959
0.9304 High Similarity NPC474240
0.9304 High Similarity NPC41301
0.9299 High Similarity NPC66618
0.9299 High Similarity NPC167678
0.9299 High Similarity NPC266314
0.9299 High Similarity NPC198829
0.9299 High Similarity NPC84324
0.9299 High Similarity NPC61010
0.9299 High Similarity NPC305987
0.9299 High Similarity NPC165970
0.9299 High Similarity NPC113163
0.9299 High Similarity NPC349525
0.9299 High Similarity NPC3629
0.9299 High Similarity NPC288131
0.9299 High Similarity NPC29876
0.9295 High Similarity NPC85121
0.9295 High Similarity NPC469658
0.9295 High Similarity NPC284127
0.9295 High Similarity NPC172202
0.9295 High Similarity NPC187792
0.9295 High Similarity NPC476410
0.9295 High Similarity NPC210459
0.929 High Similarity NPC138243
0.929 High Similarity NPC170026
0.929 High Similarity NPC255106
0.929 High Similarity NPC235165
0.929 High Similarity NPC472455
0.929 High Similarity NPC133970
0.929 High Similarity NPC24640
0.929 High Similarity NPC6633
0.929 High Similarity NPC78492
0.929 High Similarity NPC282307
0.929 High Similarity NPC68093
0.929 High Similarity NPC191146
0.929 High Similarity NPC471500
0.929 High Similarity NPC5322
0.929 High Similarity NPC208152
0.9286 High Similarity NPC33051

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC174953 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9539 High Similarity NPD2393 Clinical (unspecified phase)
0.9474 High Similarity NPD1934 Approved
0.9367 High Similarity NPD6166 Phase 2
0.9367 High Similarity NPD6167 Clinical (unspecified phase)
0.9367 High Similarity NPD6168 Clinical (unspecified phase)
0.9136 High Similarity NPD7074 Phase 3
0.9074 High Similarity NPD7054 Approved
0.9038 High Similarity NPD2801 Approved
0.9018 High Similarity NPD7472 Approved
0.8968 High Similarity NPD4380 Phase 2
0.8875 High Similarity NPD5494 Approved
0.8848 High Similarity NPD6797 Phase 2
0.8824 High Similarity NPD1511 Approved
0.8805 High Similarity NPD4868 Clinical (unspecified phase)
0.8805 High Similarity NPD3882 Suspended
0.8795 High Similarity NPD7251 Discontinued
0.878 High Similarity NPD3818 Discontinued
0.8743 High Similarity NPD7808 Phase 3
0.871 High Similarity NPD1512 Approved
0.8645 High Similarity NPD4378 Clinical (unspecified phase)
0.8634 High Similarity NPD4381 Clinical (unspecified phase)
0.8634 High Similarity NPD7075 Discontinued
0.8631 High Similarity NPD4338 Clinical (unspecified phase)
0.8625 High Similarity NPD3817 Phase 2
0.8614 High Similarity NPD7804 Clinical (unspecified phase)
0.8589 High Similarity NPD6959 Discontinued
0.8562 High Similarity NPD7096 Clinical (unspecified phase)
0.8553 High Similarity NPD1550 Clinical (unspecified phase)
0.8553 High Similarity NPD1552 Clinical (unspecified phase)
0.8512 High Similarity NPD7993 Clinical (unspecified phase)
0.8509 High Similarity NPD8443 Clinical (unspecified phase)
0.8503 High Similarity NPD5844 Phase 1
0.8497 Intermediate Similarity NPD1549 Phase 2
0.8408 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8385 Intermediate Similarity NPD6801 Discontinued
0.8333 Intermediate Similarity NPD7819 Suspended
0.8333 Intermediate Similarity NPD1465 Phase 2
0.8323 Intermediate Similarity NPD7411 Suspended
0.8313 Intermediate Similarity NPD6232 Discontinued
0.8274 Intermediate Similarity NPD7473 Discontinued
0.8247 Intermediate Similarity NPD2796 Approved
0.8246 Intermediate Similarity NPD6559 Discontinued
0.8182 Intermediate Similarity NPD1510 Phase 2
0.8158 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8158 Intermediate Similarity NPD1613 Approved
0.8113 Intermediate Similarity NPD6799 Approved
0.8061 Intermediate Similarity NPD5402 Approved
0.8039 Intermediate Similarity NPD1240 Approved
0.8 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7963 Intermediate Similarity NPD5403 Approved
0.7961 Intermediate Similarity NPD3027 Phase 3
0.7947 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7935 Intermediate Similarity NPD1607 Approved
0.7929 Intermediate Similarity NPD1247 Approved
0.7927 Intermediate Similarity NPD6599 Discontinued
0.7922 Intermediate Similarity NPD943 Approved
0.7917 Intermediate Similarity NPD919 Approved
0.7904 Intermediate Similarity NPD7768 Phase 2
0.7895 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD2800 Approved
0.784 Intermediate Similarity NPD5401 Approved
0.784 Intermediate Similarity NPD2533 Approved
0.784 Intermediate Similarity NPD2532 Approved
0.784 Intermediate Similarity NPD2534 Approved
0.7803 Intermediate Similarity NPD7228 Approved
0.7799 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD2935 Discontinued
0.7756 Intermediate Similarity NPD230 Phase 1
0.7751 Intermediate Similarity NPD3749 Approved
0.775 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7735 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD3926 Phase 2
0.7722 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD6234 Discontinued
0.7702 Intermediate Similarity NPD3750 Approved
0.7702 Intermediate Similarity NPD4628 Phase 3
0.7701 Intermediate Similarity NPD3751 Discontinued
0.7674 Intermediate Similarity NPD3787 Discontinued
0.7673 Intermediate Similarity NPD6099 Approved
0.7673 Intermediate Similarity NPD6100 Approved
0.7654 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD8312 Approved
0.764 Intermediate Similarity NPD8313 Approved
0.7636 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD37 Approved
0.7616 Intermediate Similarity NPD7199 Phase 2
0.7595 Intermediate Similarity NPD6651 Approved
0.759 Intermediate Similarity NPD1653 Approved
0.7588 Intermediate Similarity NPD4965 Approved
0.7588 Intermediate Similarity NPD4966 Approved
0.7588 Intermediate Similarity NPD4967 Phase 2
0.7584 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD1551 Phase 2
0.7561 Intermediate Similarity NPD7390 Discontinued
0.7554 Intermediate Similarity NPD4360 Phase 2
0.7554 Intermediate Similarity NPD4363 Phase 3
0.7546 Intermediate Similarity NPD6190 Approved
0.7532 Intermediate Similarity NPD447 Suspended
0.7531 Intermediate Similarity NPD1243 Approved
0.753 Intermediate Similarity NPD920 Approved
0.7528 Intermediate Similarity NPD7685 Pre-registration
0.75 Intermediate Similarity NPD8151 Discontinued
0.75 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7487 Intermediate Similarity NPD7584 Approved
0.7485 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7472 Intermediate Similarity NPD5953 Discontinued
0.7458 Intermediate Similarity NPD7286 Phase 2
0.7455 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD6780 Approved
0.7447 Intermediate Similarity NPD6778 Approved
0.7447 Intermediate Similarity NPD6776 Approved
0.7447 Intermediate Similarity NPD6782 Approved
0.7447 Intermediate Similarity NPD6781 Approved
0.7447 Intermediate Similarity NPD6777 Approved
0.7447 Intermediate Similarity NPD6779 Approved
0.744 Intermediate Similarity NPD3226 Approved
0.7436 Intermediate Similarity NPD4908 Phase 1
0.7429 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD1933 Approved
0.7421 Intermediate Similarity NPD5124 Phase 1
0.7421 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7418 Intermediate Similarity NPD8150 Discontinued
0.741 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD2346 Discontinued
0.7394 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD2799 Discontinued
0.7391 Intermediate Similarity NPD7033 Discontinued
0.7391 Intermediate Similarity NPD3748 Approved
0.7378 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD9494 Approved
0.7371 Intermediate Similarity NPD5710 Approved
0.7371 Intermediate Similarity NPD5711 Approved
0.7368 Intermediate Similarity NPD8455 Phase 2
0.7362 Intermediate Similarity NPD2424 Discontinued
0.7342 Intermediate Similarity NPD2313 Discontinued
0.7338 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7240 Approved
0.7333 Intermediate Similarity NPD7783 Phase 2
0.733 Intermediate Similarity NPD7435 Discontinued
0.733 Intermediate Similarity NPD7697 Approved
0.733 Intermediate Similarity NPD7696 Phase 3
0.733 Intermediate Similarity NPD7698 Approved
0.7322 Intermediate Similarity NPD8434 Phase 2
0.732 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD7266 Discontinued
0.7301 Intermediate Similarity NPD2344 Approved
0.7278 Intermediate Similarity NPD4625 Phase 3
0.7268 Intermediate Similarity NPD7701 Phase 2
0.7251 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD5353 Approved
0.7212 Intermediate Similarity NPD6674 Discontinued
0.7209 Intermediate Similarity NPD6844 Discontinued
0.7208 Intermediate Similarity NPD1610 Phase 2
0.7202 Intermediate Similarity NPD7870 Phase 2
0.7202 Intermediate Similarity NPD7871 Phase 2
0.7188 Intermediate Similarity NPD6823 Phase 2
0.7182 Intermediate Similarity NPD3823 Discontinued
0.7181 Intermediate Similarity NPD6534 Approved
0.7181 Intermediate Similarity NPD6535 Approved
0.7158 Intermediate Similarity NPD7699 Phase 2
0.7158 Intermediate Similarity NPD7700 Phase 2
0.7143 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4361 Phase 2
0.7135 Intermediate Similarity NPD7458 Discontinued
0.7135 Intermediate Similarity NPD5242 Approved
0.7134 Intermediate Similarity NPD1203 Approved
0.7126 Intermediate Similarity NPD2309 Approved
0.7125 Intermediate Similarity NPD6798 Discontinued
0.7119 Intermediate Similarity NPD8127 Discontinued
0.7115 Intermediate Similarity NPD4749 Approved
0.7108 Intermediate Similarity NPD1652 Phase 2
0.7108 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD6832 Phase 2
0.7107 Intermediate Similarity NPD7874 Approved
0.7107 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD2403 Approved
0.7092 Intermediate Similarity NPD7585 Approved
0.7079 Intermediate Similarity NPD7229 Phase 3
0.7071 Intermediate Similarity NPD7801 Approved
0.7059 Intermediate Similarity NPD1548 Phase 1
0.7051 Intermediate Similarity NPD9269 Phase 2
0.7047 Intermediate Similarity NPD2493 Approved
0.7047 Intermediate Similarity NPD2494 Approved
0.7044 Intermediate Similarity NPD2861 Phase 2
0.7041 Intermediate Similarity NPD7583 Approved
0.7037 Intermediate Similarity NPD4060 Phase 1
0.7031 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7026 Intermediate Similarity NPD8320 Phase 1
0.7026 Intermediate Similarity NPD8319 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data